Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent advances in chronopharmacokinetics: methodological problems

B Bruguerolle1, B Lemmer

  • 1Medical and Clinical Pharmacology Laboratory, Faculty of Medicine of Marseille, France.

Life Sciences
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The performance of the jet trigger for the ATLAS detector during 2011 data taking.

The European physical journal. C, Particles and fields·2017
Same author

Search for new phenomena in different-flavour high-mass dilepton final states in <i>pp</i> collisions at [Formula: see text] Tev with the ATLAS detector.

The European physical journal. C, Particles and fields·2017
Same author

Search for bottom squark pair production in proton-proton collisions at [Formula: see text] TeV with the ATLAS detector.

The European physical journal. C, Particles and fields·2017
Same author

Search for gluinos in events with an isolated lepton, jets and missing transverse momentum at [Formula: see text] = 13 Te V with the ATLAS detector.

The European physical journal. C, Particles and fields·2017
Same author

Search for single production of vector-like quarks decaying into <i>Wb</i> in <i>pp</i> collisions at [Formula: see text] TeV with the ATLAS detector.

The European physical journal. C, Particles and fields·2017
Same author

Search for supersymmetry in a final state containing two photons and missing transverse momentum in [Formula: see text] = 13 TeV [Formula: see text] collisions at the LHC using the ATLAS detector.

The European physical journal. C, Particles and fields·2017
Same journal

Corrigendum to "Adipose stem cells-derived microvesicles and chicken egg-derived exosomes attenuate cardiac ischemia/reperfusion injury through AKT/ERK/Nrf2/HO-1 axis to inhibit apoptosis and inflammation and restore autophagy" [Life Sci. 395 (2026) 124364].

Life sciences·2026
Same journal

MAGED1 stabilizes NEUROD1 to promote Per3 expression in the pineal gland.

Life sciences·2026
Same journal

TNF-centered network pharmacology and molecular modeling of selected Andrographis paniculata compounds in hypertension.

Life sciences·2026
Same journal

Retraction notice to "Beneficial effect of Calculus Bovis Sativus on 17α-ethynylestradiol-induced cholestasis in the rat" [Life Sci. 113 (2014) 22-30].

Life sciences·2026
Same journal

Soluble PD-1 drives renal fibrosis in CKD by disrupting immune homeostasis: Therapeutic mitigation via a targeted sPD-1 sequestration strategy.

Life sciences·2026
Same journal

METTL1 promotes hepatic steatosis by mediating m<sup>7</sup>G modification of ALOX15B mRNA.

Life sciences·2026
See all related articles

Chronopharmacokinetics studies how drug absorption, distribution, metabolism, and elimination change over time. Understanding these temporal variations is crucial for optimizing drug efficacy and safety, especially for drugs with narrow therapeutic ranges or circadian-dependent effects.

Area of Science:

  • Pharmacokinetics and chronobiology
  • Drug metabolism and disposition
  • Temporal variations in drug action

Background:

  • Chronopharmacokinetics investigates time-dependent changes in drug pharmacokinetic processes.
  • Numerous studies highlight the impact of administration timing on drug behavior.
  • Temporal variations affect drug absorption, distribution, metabolism, and elimination.

Purpose of the Study:

  • To review recent advances in chronokinetics.
  • To illustrate chronokinetic changes in anesthetics, cardiovascular drugs, and anti-inflammatory agents.
  • To emphasize the importance of administration timing in pharmacokinetic studies.

Main Methods:

  • Review of recent chronokinetic studies.
  • Listing of representative chronokinetic changes for specific drug classes in humans.

Related Experiment Videos

  • Identification of factors influencing pharmacokinetic variability.

    • Main Results:

    • Temporal variations occur at all pharmacokinetic stages: absorption, distribution, metabolism, and excretion.
    • Drug administration time is a significant source of pharmacokinetic variation.
    • Specific examples of chronokinetic changes in anesthetics, cardiovascular, and anti-inflammatory drugs are provided.

    Conclusions:

    • Chronokinetic studies are essential when daily pharmacokinetic variations influence drug effects.
    • These studies are critical for drugs with narrow therapeutic ranges or circadian-dependent disease symptoms.
    • Controlling variables like meal times, formulation, and posture is vital for accurate chronokinetic analysis.